Drug Name: Brenzavvy
Indications: To improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
Active Ingredient: Bexagliflozin
Company: TheracosBio, LLC
Approval Date: 1/20/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214373s000lbl.pdf